Parameters | No. of patients | D2R | P | MGMT | P | VEGF | P | |||
---|---|---|---|---|---|---|---|---|---|---|
Low | High | Low | High | Low | High | |||||
Cases | 197 | 69 | 128 | Â | 170 | 27 | Â | 81 | 116 | Â |
Gender | Â | Â | Â | 0.736 | Â | Â | 0.826 | Â | Â | 0.646 |
Male | 106 | 36 | 70 | 92 | 14 | 42 | 64 | |||
Female | 91 | 33 | 58 | 78 | 13 | 39 | 52 | |||
Aggressive | Â | Â | Â | 0.410 | Â | Â | 0.220 | Â | Â | 0.602 |
Yes | 64 | 25 | 39 | 58 | 6 | 28 | 36 | |||
No | 133 | 44 | 89 | 112 | 21 | 53 | 80 | |||
Recurrence | Â | Â | Â | 0.741 | Â | Â | 0.096 | Â | Â | 0.199 |
Yes | 16 | 5 | 11 | 16 | 0 | 9 | 7 | |||
No | 181 | 64 | 117 | 154 | 27 | 72 | 109 | |||
Tumor size | Â | Â | Â | 0.829 | Â | Â | 0.884 | Â | Â | 0.823 |
≤10 mm | 16 | 6 | 10 | 14 | 2 | 7 | 9 | |||
>10Â mm | 181 | 63 | 118 | 156 | 25 | 74 | 107 | |||
Tumor texture | Â | Â | Â | 0.309 | Â | Â | 0.913 | Â | Â | 0.090 |
Tender | 159 | 53 | 106 | 137 | 22 | 70 | 89 | |||
Tenacious | 38 | 16 | 22 | 33 | 5 | 11 | 27 | |||
Bromocriptine | Â | Â | Â | 0.096 | Â | Â | 0.919 | Â | Â | 0.344 |
Yes | 8 | 5 | 3 | 7 | 1 | 2 | 6 | |||
No | 189 | 64 | 125 | 163 | 26 | 79 | 110 |